Clinical trial
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper…
NCT00045799 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00045799 |
|---|---|
| Title | Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill |
| Official title | Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Upper Gastrointestinal Bleeding |
| Intervention type | Drug |
| Interventions | Omeprazole sodium bicarbonate immediate release PWD/FS, Cimetidine IV |
| Enrollment | 354 |
| Start date | May 1, 2002 |
| Completion | May 1, 2003 |
| First posted | Sep 11, 2002 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: